Randomised Phase 3 trial demonstrating high efficacy, favourable safety, and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis.
Andreas PinterA ReichMonika ArenbergerovaLinda F Stein GoldA ArmstrongL IversenM PraestegaardMatthias AugustinPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
CAL/BDP PAD-cream is a novel topical treatment of psoriasis that has a high efficacy and a favourable safety profile combined with a superior patient reported treatment convenience.